| Apr. | 2008 | Established a subsidiary, CarnaBio USA, Inc. in Massachusette |
|---|---|---|
| Mar., | 2008 | Newly listed share on jasdaq NEO market |
| Oct. | 2007 | Signed collaboration and service agreement with OSI Pharmaceuticals, Inc. |
| Apr. | 2007 | Signed collaborative research and development agreement with SBI Biotech Co., Ltd. and CrystalGenomics, Inc. (2nd step) |
| July, | 2006 | Signed distributorship agreement with KinaseDetect ApS, Denmark |
| April, | 2006 | Signed collaboration agreement with Enamine Ltd., Ukraina |
| Mar., | 2006 | Formed strategic alliance with ChemDiv Inc, USA to develop and market library. |
| Fed., | 2006 | Signed collaboration agreement with Ginkgo Biomedical Research Institute Co., Ltd. (presently SBI Biotech Co., Ltd.) and CrystalGenomics, Inc.(1st step) |
| Feb., | 2005 | Signed a distribution agreement with CrystalGenomics, Inc., Korea |
| Oct., | 2004 | Partnering with Fujirebio Inc. for collaborative research and development |
| Aug., | 2004 | Opened a new laboratory in the Biomedical Accelerator (BMA) |
| June, | 2004 | Began collaborative research with CrystalGenomics, Inc., Korea. |
| Oct., | 2003 | Began collaboration with IBL Co.,Ltd. |
| Oct., | 2003 | Opened office at Kobe Port Island II headquarters |
| April, | 2003 | Company founded. |
